TY  - RPRT
TI  - Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subdermal implant
AU  - Kim, H.-y.
AU  - Zhang, L.
AU  - Hendrix, C. W.
AU  - Haberer, J. E.
AU  - von Kleist, M.
PY  - 2024
DO  - 10.1101/2024.04.15.589489
UR  - https://www.biorxiv.org/content/10.1101/2024.04.15.589489v1
ID  - 10.1101/2024.04.15.589489
ER  -